CRP and metastatic prostate carcinoma: Two additional studies have found no difference between CRP levels in patients with benign hyperplasia and localized prostate cancer, but found statistically significant differences in CRP level between benign hyperplasia and patients with metastatic prostate cancer (48, 51).